The field of vascular medicine or
Angiology is the field that deals with preventing, diagnosing and treating vascular and blood vessel-related diseases.
Coleridge Smith et al., "Indications for compression therapy in venous and lymphatic disease: Consensus based on experimental data and scientific evidence under the auspices of the IUP," International
Angiology, vol.
Kistner, "Venous hemodynamic changes in lower limb venous disease: the UIP consensus document," International
Angiology, vol.
Celik et al., "Neutrophil to lymphocyte ratio is related to stent thrombosis and high mortality in patients with acute myocardial infarction,"
Angiology, vol.
Cooke, "Noninvasive measurement of the human peripheral circulation: relationship between laser Doppler flowmeter and photoplethysmograph signals from the finger,"
Angiology, vol.
The study was funded by the Foundation for the Development of Vascular Surgery at the Department of Vascular Surgery and
Angiology, Medical University of Lublin, Lublin, Poland.
Twenty-seven-year-old man who worked as a car mechanic was admitted to the Department of
Angiology, Arterial Hypertension and Diabetology of the Wroclaw Medical University due to critical ischemia of the fingers of the dominant right arm.
According to a new peer-reviewed study published in the International Journal of
Angiology, Pycnogenol, a standardized natural plant extract from French maritime pine tree bark, may significantly improve the appearance, swelling and discomfort of pregnancy-induced varicose veins and spider vein clusters.
In 28 chapters,
angiology, vascular, cardiology, and other specialists from Europe, the US, Australia, and Indonesia describe diseases of the arteries and veins, inflammatory vascular diseases, and congenital vascular diseases, with information on the clinical picture, clinical findings, diagnosis, treatment, and the prognosis and course.
Consensus document of the International Union of Phlebology (IUP)-2009," International
Angiology, vol.
Zippel brings more than 13 years of experience within the medical device, CRO, and biotech industries, and has specific expertise managing medical device clinical studies throughout Europe in the fields of cardiology,
angiology, anesthesia/intensive care, orthopedics and neurology.
HPH 2012 was held in Havana earlier this month to market Heberprot-P[R]--a drug developed by Havana's Genetics and Biotechnology Center (CIGB) and the National Institute of
Angiology and Vascular Surgery, and distributed by Heber Biotec SA.